Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vomiting × Palonosetron × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4 Gastrointestinal 3 Other hematologic neoplasm 2 Lymphoid 2 Head & Neck 2 Thoracic 1 Sarcoma 1 Dermatologic 1

Conditions

Vomiting 1 Nausea 1 Lung Neoplasms 1

Interventions

Dexamethasone 3 Aprepitant 2 netupitant, palosentron drug combination 1 netupitant 1 fosaprepitant 1 casopitant 1 Yoga 1 Therapeutics 1 Radiotherapy 1 Palonosetron 1 Ondansetron 1 Olanzapine 1 Exercise 1 Analgesia 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Zhejiang University

Phase 2 Unknown

Lung Neoplasms, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡